Financials
- Market Capitalization 479.78 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.53
Fiyat/satışlar oranı
8.08
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2899 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.37 USD | -3.13% | +0.60% | +15.61% | +133.15% | 517.63 M USD | ||
| 2937 | EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -4.24% | +0.64% | +21.54% | +25.40% | 485.31 M USD | ||
| 2944 | PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +9.76% | +14.20% | 478.97 M USD | ||
| 2954 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +9.07% | +49.81% | 473.65 M USD |